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Para-Aortic-Splanchnopleura (PSp)More than a century ago, several embryologists described sites of hematopoietic activity in the vascular wall
of mid-gestation vertebrate embryos, and postulated the transient existence of a blood generating endothe-
lium during ontogeny. This hypothesis gained signiﬁcant attention in the 1970s when orthotopic transplan-
tation experiments between quail and chick embryos revealed speciﬁc vascular areas as the site of the origin
of deﬁnitive hematopoiesis. However, the vascular origin of hematopoietic precursors remained elusive and
controversial for decades. Only recently, multiple experimental approaches have clearly documented that
during vertebrate development deﬁnitive hematopoietic precursors arise from a subset of vascular endothe-
lial cells. Interestingly, this differentiation is promoted by the intravascular ﬂuid mechanical forces generated
by the establishment of blood ﬂow upon the initiation of heartbeat, and it is therefore connected with cardio-
vascular development in several critical aspects. In this review we present our current understanding of the
relationship between vascular and deﬁnitive hematopoietic development through an historical analysis of
the scientiﬁc evidence produced in this area of investigation.BrighamandWomen's Hospital,
SA. Fax: +617.525.4329.
ard.edu (G. García-Cardeña).
sevier Inc.© 2011 Published by Elsevier Inc.Vascular endothelium and hematopoietic cells are in a close
relationship during ontogeny: the hemangioblast and the
hemogenic endothelium
The inner surface of blood vessels is covered by a single layer of
cells called the vascular endothelium. As an active cellular interface
located between intravascular content and the tissues throughout
the body (Gimbrone, 1995), the endothelium is known to display
functional and morphological heterogeneity throughout the vascula-
ture (Aird, 2007), but is typically considered a terminally differentiat-
ed cell type (Cleaver andMelton, 2003). While this view describes the
endothelium present in most vascular beds, an important exception
to this paradigm is offered by the hemogenic endothelium, a special
type of endothelium endowed with the capacity to differentiate into
blood cell precursors (Smith and Glomski, 1982).
The existence of an endothelium with hemogenic properties was
ﬁrst described between the end of the 1800s and the beginning of
the 1900s. At that time, a number of investigators reported the pres-
ence of clusters of cells of the hematopoietic lineage (hemoblasts) in
close connection with the endothelium of the ventrolateral aspect of
the developing aorta in embryos of vertebrates including the bat(Stricht, 1899), the mongoose (Jordan, 1917), the chick (Dantschakoff,
1907), the pig (Emmel, 1916), the rabbit (Maximow, 1909) and the
human (Minot, 1912). By 1916, considering the data produced in the
previous two decades, H Jordan wrote “there seems to be no escape
from the interpretation of such clusters of hemoblasts as derivatives
from the ventral endothelium of the aorta” (Jordan, 1916), and by
1917 Sabin was reporting the in vivo observation of developing “red-
blood corpuscles” from the “endothelial lining of blood vessels” in the
chick embryo (Sabin, 1917). Importantly, Sabin observed the presence
of aggregates of cells or single cells, formed from the mesenchyme,
from which both endothelial cells delimiting the vascular lumen and
clusters of blood cells developed. In 1920, Sabin reﬁned this observa-
tion and reported the existence, in the developing chick blastoderm,
of mesodermal clusters derived from the proliferation of angiohemato-
poietic cells that give rise to hematopoietic cells in the center and en-
dothelial cells in the periphery, suggesting that some blood cells arise
secondarily from hematogenous yolk sac endothelial cells (Sabin,
1920). These observations were broadened a few years later byMurray
(Murray, 1932). Murray called these multipotent angiohematopoietic
mesenchyme-derived cells “hemangioblasts”, or a common precursor
to both endothelium and blood. He also clearly stated for the ﬁrst
time that the data reported up to that time suggested the existence
not only of a common precursor for endothelial and hematopoietic
cells (the hemangioblast) but also of an endothelium that “retains, at
least for some time, the power of giving rise to new erythroblasts”
(Fig. 1).
Fig. 1. Early description of endothelium associated hematopoietic activity. Left, representation of hematopoieic clusters in the ventral aspect of the aorta of a 9 mm pig embryo.
Right, representation of cytological changes observed in the endothelium of a 12 mm pig embryo in proximity of hematopoeitc cells clusters. Reproduced from V. Emmel, The Amer-
ican Journal of Anatomy, Vol 19, No 3, 1916.
Fig. 2. Experimental strategy for the generation and analysis of yolk sac chimeras. An em-
bryonic day 2 (E2) quail embryo body (blue) is used to replace a chick embryo body on the
chick blastoderm (presumptive yolk sac) before the circulation is established. After several
days of in ovo development (E4–E13), the spleen and thymus tissues of the transplanted
embryo are examined for a natural marker that distinguishes quail cells from chick cells.
Quail cells contain a characteristically large, irregular nucleus, with a large heterochromat-
ic mass, whereas chick cells contain ﬁnely dispersed heterochromatin. The results show
that the progeny of cells derived from the quail embryo body (and not the chick yolk
sac) contributes to the hematopoietic cell population in these tissues. (Reproduced with
permission from Development. 2008 Aug; 135(14):2343–6).
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deﬁnitive hematopoiesis
While the work described in the previous section established the
existence of a close connection between endothelial and hematopoietic
cell development during ontogenesis, many questions about this rela-
tionship remained unanswered, among those, the nature and the im-
portance of the hemangioblast and of the hemogenic endothelium.
These questions were not investigated in detail for many years proba-
bly, at least in part, because some experiments performed by Moore
and Owen in the 1960s (Moore and Owen, 1965; Moore and Owen,
1967) suggested that all adult hematopoiesis was initiated in extraem-
bryonic tissues (the yolk sac). Therefore, it was thought that the sites of
intraembryonic hematopoiesis were merely intermediate stages of a
process of embryonic colonization from progenitors differentiated in
the yolk sac.
It is important to note that during mammalian development two
waves of hematopoiesis have been documented. The ﬁrst wave of
primitive hematopoiesis takes place at gastrulation in the yolk sac
mesoderm and produces large, nucleated erythroid cells but does
not produce cells of the adaptive immune system. A second wave of
deﬁnitive hematopoiesis takes place later and is marked by the ap-
pearance of enucleated erythroid cells, pluripotent lymphoid progeni-
tors, and the presence of long term hematopoietic stem cells (HSCs), or
cells able to colonize the deﬁnitive hematopoietic organs and eventually
give rise to all different blood cell lineages (Dzierzak and Speck, 2008;
Lensch and Daley, 2004). While at the time of the appearance of the
ﬁrst wave of hematopoiesis, blood generation is apparent only in the
extraembryonic tissues, during the secondwave of “deﬁnitive” hemato-
poiesis, blood-forming activity is evident in both extraembryonic and
intraembryonic tissues. As mentioned before, work from Moore
and Owen in the 1960s suggested that hematopoiesis began only
once in the yolk sac and that progenitors generated in these extra-
embryonic tissues were responsible for colonizing intraembryonic
hematopoietic sites and eventually for the initiation of deﬁnitive
hematopoiesis.
Hematopoietic activity of the intraembryonic vasculature was called
back to the attention of the scientiﬁc community by a series of experi-
ments based on the grafting of quail embryonic tissues onto chick em-
bryos. These experiments demonstrated that the hemogenic activity
of the aorta was tightly connected to the development of deﬁnitive he-
matopoietic stem cells (Dieterlen-Lievre, 1975), challenging the model
proposed by Moore and Owen. The group of Françoise Dieterlen-Lièvre
performed these elegant experiments using an orthotopic transplanta-
tion system in which two-day old (pre-circulation) quail embryos
were grafted onto chick yolk sacs of comparable developmental stage.
Since quail and chick hematopoietic cells are easily distinguishable by
visual inspection, and the orthotopic transplant does not signiﬁcantly
affect embryo development, this experimental system made it possible
to assess the contribution of intraembryonic and extraembryonic tis-
sues to the production of blood cells. Analyzing quail- chick chimeras,
Dieterlen-Lièvre arrived at the conclusion that in the late stage avianembryo all blood cells originated from intraembryonic sites with no
contribution from the yolk sac and, therefore, deﬁnitive hematopoiesis
must be originate within the embryo. Furthermore, Dieterlen-Lievre
and Martin (1981) reported that in the avian system hematopoietic ac-
tivity was only present in the ventrolateral aspect of the aorta. These
data indicated an exquisite, regionalized activity of a speciﬁc area of
the developing vascular wall.
These observations led to the hypothesis that the intraembryonic
sites of the origin of the hematopoietic stem cells were the aortic
erythropoietic loci described almost 80 years before (Fig. 2).
Functional role of the hemogenic endothelium at vascular hemogenic sites
The observations summarized above raised a new series of criti-
cal questions: Are hematopoietic cells budding off of a “hemogenic
endothelium”, as suggested by Jordan in 1916? Are hematopoietic
cells derived from the mesoderm underneath the endothelium?
Alternatively, do they come from a hemangioblast-like cell that pro-
duces both hematopoietic cells and endothelial cells without requiring
an endothelial intermediate? In addition to these questions, it was
also important to deﬁne whether the observations made in the avian
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other vertebrates?
The ﬁrst evidence suggesting that vascular hematopoietic activity
was coming from cells of endothelial nature, and not from meso-
derm-derived cells simply in transit through the developing vascular
walls, came in 1982 from ultrastructural studies. These morphological
analyses showed the presence of intercellular junctions and ultra-
structural similarities between endothelial cells of the ventrolateral
aspect of the aorta and the hemogenic clusters protruding into the
lumen of the vessel. These datawere soon reinforced by theﬁrst reports
of a monoclonal antibody able to speciﬁcally stain endothelial cells and
the developing intraaortic blood islands in the quail (Pardanaud et al.,
1987; Peault et al., 1983). Importantly, the ultrastructural studies were
performed in gerbil, pig and human embryos, suggesting once more
that the aortic hematopoiesis associated with the endothelium was a
conserved phenomenon and not something speciﬁc to the avian system.
The relevance of these data to all vertebrates became clear only
when the ﬁndings from the avian embryos were conﬁrmed in the
mouse system. It was ﬁrst shown that in the mouse it is possible to
identify hematopoietic progenitors in the developing aorta at the
level of the Aorta-Gonads-Mesonephros (AGM) region before their
appearance in the liver or in other hematopoietic organs (Godin
et al., 1993; Medvinsky et al., 1993), and that the aorta of the day
10.5 murine embryo shows hematopoietic clusters similar to those
observed in the quail and in the chick (Garcia-Porrero et al., 1995).
It was ﬁnally observed that the presence of these clusters is related
to the establishment of deﬁnitive hematopoiesis (Cumano et al., 1996;
Medvinsky and Dzierzak, 1996). Collectively, these studies documented
that both the existence of hematopoietic clusters and the presence of
hematopoietic activity are transient in the AGM, and they appear
around day 10 of embryonic development and quickly disappear after
peaking at day 11.5.
New tools to conﬁrm the common origin of endothelial and hematopoietic
progenitors: animal models and the ES system
The validation of the ﬁndings in the avian system in the murine
model conﬁrmed the importance of intraembryonic hematopoiesis in
the ventrolateral aspect of the aorta and suggested that the ﬁndings of
Dieterlen-Lièvre and coworkers were relevant to other vertebrates
(Cumano et al., 1996; Medvinsky and Dzierzak, 1996). However, the
identiﬁcation of deﬁnitive hematopoietic activity in themurine embryo
at the level of the AGMdid not provide further understanding of the de-
velopmental relationship between the endothelium and hematopoietic
cells. Signiﬁcant progress on this topic was made possible by the de-
scription of new mutations producing a defect in both endothelial and
hematopoietic lineages and by the study of murine embryonic stem
cells.
In 1995, Stainier et al. described for the ﬁrst time a genetic locus
affecting both endothelial and hematopoietic differentiation. Through
a large-scale mutagenesis screen in the zebraﬁsh (Danio rerio), they
identiﬁed “cloche”, a mutant showing a selective defect in endothelial
cells at the endocardial level and a defect in hematopoiesis. Interesting-
ly, the endocardial defect of the clochemutant was associatedwith a re-
duction in heart contractility (Stainier et al., 1995). This reportwas soon
followed by a report of a Flk1 knock-out mouse as the ﬁrst mouse mu-
tant showing defects in the maturation of both hematopoietic and en-
dothelial lineages (Shalaby et al., 1995) and by the description of a
Tie2/TEK null mouse showing defects in vasculogenesis (Dumont et
al., 1994) and deﬁnitive hematopoiesis (Takakura et al., 1998). In the
avian embryo, Flk1was shown to be expressed in a population ofmeso-
dermal cells able to give rise to hematopoietic or endothelial colonies
depending on the absence or presence of the ligand of Flk1, vascular en-
dothelial grow factor (VEGF) (Eichmann et al., 1997).
At the same time that these data were published, Jaffredo et al.
reported the ﬁrst functional data supporting the endothelial originof hematopoietic clusters in the aorta. Using the avian embryo as a
model, they labeled the endothelium by injecting traceable acetylated
LowDensity Lipoproteins (Ac-LDL) into theheart before the appearance
of the intraaortic hematopoietic clusters and showed that the hemato-
poietic clusters that appeared 24 h later were bearing the Ac-LDL label
that was initially present exclusively in the endothelium (Jaffredo et
al., 1998). Soon after, these authors obtained similar results by labeling
endothelial cells with retroviral vectors (Jaffredo et al., 2000).
A more detailed understanding of the relationship between the
mesoderm, endothelial cells and hematopoietic progenitors was
obtained by studying embryonic stem (ES) cell differentiation. ES
cells are pluripotent cells derived from the inner cells mass of early
embryos. ES cells can be differentiated into all embryonic lineages
and ultimately into all embryonic cell types. When a suspension of
ES cells is partitioned in hanging drops a few microliters in volume,
ES cells self-aggregate and grow as spherical structures called “em-
bryoid bodies” (EB). While growing as embryoid bodies, ES cells dif-
ferentiate into the three embryonic lineages reproducing the cell
commitment events of early embryogenesis (Desbaillets et al.,
2000). Therefore, the embryoid body system offers an opportunity
to differentiate hematopoietic progenitors in vitro and to study their
cellular origin. By analyzing ES-derived cells at different stages of dif-
ferentiation and performing cell sorting followed by further in vitro
differentiation, the group of Gordon Keller was the ﬁrst to demon-
strate that hematopoietic cells can be differentiated from Flk1+ cells
(Kabrun et al., 1997). Flk1 is the murine homolog of VEGFR-2, a recep-
tor for vascular endothelial growth factor, and a typical endothelial
marker that was also found to be expressed in hematopoietic sites in
vivo and that, as mentioned above, had been found to be essential for
both vasculogenesis and hematopoiesis in vivo (Shalaby et al., 1997).
Soon after the publication of these ﬁndings, the same group brought
the murine ES model one step further by demonstrating that cells of
both hematopoietic and endothelial lineages can be differentiated
from hemangioblast-like precursors that appear in murine ES-derived
cells after about 3 days of differentiation using the embryoid body
method (Choi et al., 1998). Later, the existence of the “hemangioblast”
was also conﬁrmed in human ES cells (Zambidis et al., 2008).
The use of the ES system generated the ﬁrst experimental evidence
in vitro supporting the existence of the hemangioblast. Proof of the exis-
tence of hemogenic endothelial cells came through thework of Shin-Ichi
Nishikawa. Culturing murine ES cells on type IV collagen-coated dishes,
Nishikawa showed that cells expressing both Flk1 and the endothelial
speciﬁc marker vascular endothelial cadherin (Flk1+/VE-Cadherin+
cells) are multipotent and are endowed with hematopoietic potential.
This same study reported the FACS-based isolation of VE-Cadherin+
cells with hemogenic potential from day 9.5 murine embryo yolk sacs
(Nishikawa et al., 1998).
Understanding the differences between hemogenic and non-hemogenic
endothelium
By this point in time, the scientiﬁc community had produced sub-
stantial evidence demonstrating that hematopoietic and endothelial
lineages have a common origin and that the presence of endothelium
is to some extent necessary for the maturation of intraembryonic he-
matopoietic progenitor cells. However, the relationship between
hemogenic and non-hemogenic endothelium was still not clear, and
even the existence of a hemogenic endothelium was questionable
due to the lack of a clonal assay in vivo.
Once again, studies in the avian embryo were the ﬁrst to shed
some light on these unexplored questions. Orthotopic transplantation
experiments between chick and quail embryos, in which mesodermal
fragments were switched between the two species, suggested that
during ontogeny there are two distinct endothelial lineages, one
hemogenic and one not. In fact, the endothelium of the ventrolateral
aspect of the aorta seems to originate from the splanchnic lateral
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aorta is produced by the paraxial mesoderm (Pardanaud et al.,
1996). Evidence that the endothelium of the intraembryonic vascular
hemogenic sites was different from the endothelium elsewhere came
from cell tracing experiments aimed at studying the role and expres-
sion of Cbfa2/Aml1/Runx1, a gene indispensable for the establish-
ment of deﬁnitive hematopoiesis. Studying Runx1 expression in
Runx1+/Lacz embryos, North et al. showed that the endothelium of in-
travascular hemogenic sites expresses high levels of Runx1 in a spe-
ciﬁc way. This expression is visible in the ventrolateral aspect of the
aorta as early as day 9.5 of development, peaks around day 11 of de-
velopment, and disappears before day 14, exactly like the hemogenic
activity of the region (North et al., 1999). Runx1 expression was later
shown to mark the endothelium of mid gestation vascular hemogenic
sites in the zebraﬁsh (Kalev-Zylinska et al., 2002) and in the avian
embryo (Bollerot et al., 2005) as well (Fig. 3). Interestingly, while
Runx1 is expressed in different cell types in the adult, the gene ex-
pression is controlled by two different promoters and by an intronic
enhancer with one of the two promoters and the intronic enhancer
predominantly active in cells with a hemogenic endothelial pheno-
type (Bee et al., 2010; Ng et al., 2010; Sroczynska et al., 2009). Using
the avian embryo, Myb, a synergistic partner of Runx1 (Hernandez-
Munain and Krangel, 1995) essential for AGM hematopoiesis
(Mukouyama et al., 1999), was shown to follow a Runx1-speciﬁc ex-
pression pattern in the AGM aorta (Bollerot et al., 2005). Moreover
HoxB3, a suppressor of Runx1 expression andof hematopoietic develop-
ment, was shown to follow an expression pattern complementary to
that of Runx1 in the vasculature of a midgestation mouse embryo
(Iacovino et al., 2011).
In vitro studies with ES cells and in vivo studies with transgenic ani-
mals showed that the hemogenic endothelium could also be distin-
guished from the non-hemogenic endothelium by the activity of a cis-
acting regulatory element of the Flk1 gene, the Flk1 promoter enhancer.
Hemogenic endothelial cells seem to fail to activate the Flk1 promoter
enhancer that is activated in non-hemogenic endothelial cells (Hirai et
al., 2003).
In an effort to understand the biology of the hemogenic endothe-
lium, a number of different groups sought a set of surface markers
that could help identify, in vivo, cells that express some form of endo-
thelial identity and have hematopoietic potential. In 1998, Garcia-
Porrero et al. studied the antigenic proﬁle of endothelial and hemato-
poietic precursors in histological sections of mid-gestation murine
embryos and described the intravascular hematopoietic clusters as
CD34+, CD31+, and vWF−. Besides providing some of the earliest in-
formation on the antigenic proﬁle of intravascular hematopoietic
clusters, in this report the authors named the precursor of the AGM
at day 9.5 p.c. the Para-Aortic-Splanchnopleura (PSp) and introducedFig. 3. Runx1 expression marks the hemogenic endothelium in the ventrolateral aspect
of the mid-gestation aorta. Mid-trunk section of a chicken embryo (approximately E3).
In situ hybridization with probe speciﬁc for Runx1 shows intense staining in the ven-
trolateral aspect of the Aorta (hollow structure in center). Courtesy of F. Dieterlen-
Lievre and T Jaffredo.a terminology now widely accepted in the ﬁeld (Garcia-Porrero et al.,
1998).
The ﬁrst report of a speciﬁc set of surfacemarkers for hemogenic en-
dothelial cells was published in 1999 and identiﬁed alpha4-integrin
(α4integrin) as a marker to distinguish hemogenic endothelial cells
(α4integrin+/VE-Cadherin+) from non-hemogenic endothelial cells
(α4integrin−/VE-Cadherin+). Importantly, in this study hemogenic en-
dothelial cells were isolated from both the yolk sac and the embryonic
body of day 9.5 murine embryos. α4integrin+/VE-Cadherin+ cells
were later shown to have hematopoietic potential in primate ES cells
as well (Shinoda et al., 2007).
In 2002, Fraser et al. identiﬁed in the midgestation murine embryos
a population of cells positive for both VE-Cadherin and the pan-
hematopoietic marker CD45 and showed that these cells were able to
differentiate into hematopoietic colonies but were unable to grow en-
dothelial colonies. The authors interpreted these observations as indi-
cating that VE-Cadherin+/CD45+ cells are hemogenic endothelial cells
in an advanced phase of maturation toward the hematopoietic lineage
(Fraser et al., 2002). These data also implied that hemogenic endothelial
cells are CD45−. Soon after the report from Fraser et al., Kumano et al.
showed that alterations in Notch1 signaling interfere with the matura-
tion of the hemogenic endothelium, deﬁned as either c-Kit+/CD34+
cells or VE-Cadherin+/CD45− cells. The authors found that a mutation
in Notch1 did not affect the prevalence of these cells in the yolk sac or
the Para-Aortic Splanchnopleura (PSp) of day 9.5 embryos despite its
effect on deﬁnitive hematopoiesis. This observation was interpreted
as suggesting that Notch1 signaling is necessary for the maturation
of hematopoietic progenitors from hemogenic endothelial precur-
sors (Kumano et al., 2003).
While most research groups were trying to identify the hemogenic
endothelium by a set of surface markers, Goldie et al. showed that
hemogenic endothelial activity can be identiﬁed within Flk1+/CD45−
cells by the expression of c-Kit and the Hoechst Dye Efﬂux Capacity
(the hemogenic endothelium would therefore be a side population
expressing Flk1 and c-Kit but negative for CD45). Interestingly, these
cells appear to express the Retinoic Acid (RA) receptor and their differen-
tiation is dependent on RA signaling (Goldie et al., 2008).
Studies to identify the “signature” of the hemogenic endothelium
in vivo were also performed in the human embryo (Oberlin et al.,
2010; Oberlin et al., 2002; Tavian et al., 1996; Tavian et al., 2005).
The studies in the human embryo conﬁrmed most of the observations
made in the mouse by identifying intraaortic hematopoietic clusters
as CD34+ (Tavian et al., 1996) and highlighting hematopoietic activity
in CD45− cells that were either CD34+ or CD31− but CD45− cells
(Oberlin et al., 2002). In addition, analysis of human tissues identiﬁed
Angiotensin Converting Enzyme (CD143) as a marker of intraaortic
cell clusters in the human embryo (Jokubaitis et al., 2008).
This set of data marked a signiﬁcant improvement in the molecu-
lar characterization of the hemogenic endothelium. However, all of
these ﬁndings still failed to produce in vivo evidence supporting the
development of hematopoietic precursors either from endothelial
cells or through an endothelial intermediate.
Conﬂicting evidence on the endothelial origin of hematopoietic stem cells
In the mid-gestation mouse embryo, Runx1 expression is present
in both the endothelium and in the underlying mesenchyme. The ex-
pression of Runx1 is necessary for deﬁnitive hematopoiesis but a
question remained: Do the deﬁnitive hematopoietic stem cells come
from the endothelium or from the mesenchyme? Despite the produc-
tion of extensive evidence showing that something key to the devel-
opment of adult hematopoiesis is happening in the ventrolateral
aspect of the aorta at the level of the AGM, there was still no conclusive
evidence that the hematopoietic precursors were actually coming from
the endothelium. The questionswere almost the sameones asked at the
beginning of the 1900s: Is there a hemogenic endothelium? Are
Fig. 4. Murine hematopoietic stem cells originate from the endothelium of the ventro-
lateral aspect of the aorta at the level of the AGM in vivo. VE-Cadherin cells are labeled
in the AGM region with the use of Tamoxifen inducible Cre under the control of VE-
Cadherin promoter (top panel). Labeling of VE-Cadhein positive cells in the midgesta-
tion murine embryo results in labeling of hematopoietic precursors in the bone mar-
row. (Reproduced with permission from Cell Stem Cells, (2008) 3: 625–636).
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are there endothelial cells that can differentiate into hematopoietic
progenitors during ontogeny? In order to try to answer these ques-
tions, different groups focused their studies on the relationship be-
tween the endothelium and hematopoietic stem cells in the AGM.
Using Runx1+/lacz mice, North et al. (2002) showed that hematopoi-
etic stem cells are restricted to Runx1-expressing cells but they are
present in both the endothelial and mesenchymal fractions. Howev-
er, analyzing Runx1+/+ wild type mice they found that in the pres-
ence of two Runx1 alleles, hematopoietic stem cells are present
only in the endothelial fraction, suggesting that in WT mice HSCs
come only from the hemogenic endothelium and that Runx1 hemi-
zygosis produces a hematopoietic phenotype. Two other papers pub-
lished in the same year supported these data. de Bruijn et al. (2002)
showed that by using Sca1 expression as a marker of hematopoietic
stem cells it is possible to demonstrate that HSCs localize to the endo-
thelial cell layer in the AGM aorta; Fraser at al. showed that primary
VE-Cadherin+ cells isolated from murine embryos at days 7.5 to 9.5 of
development are able to repopulate the bonemarrow of lethally irradi-
ated mice. Importantly, in this latter work, the VE-Cadherin+ trans-
planted cells were depleted of cells expressing the pan-hematopoietic
marker CD45 (Fraser et al., 2002).
While these three studies strongly support an endothelial origin of
hematopoietic stem cells and the existence of a hemogenic endothe-
lium, they were still relying heavily on only one or two endothelial
surface markers to deﬁne the endothelial nature of the HSC precur-
sors, they did not generate morphological or cell fate tracing data,
and they, therefore, did not provide deﬁnitive proof of an endothelial
origin of hematopoietic stem cells. The conclusions of these reports
were actually challenged by another study presenting evidence in
support of a subendothelial origin of HSCs (Bertrand et al., 2005). In
this study, Bertrand et al. deﬁned a surface marker signature of
AGM HSCs as cells that were c-Kit+, AA4.1+, CD31+ and CD41+ but
Flk1− and CD45−. Furthermore, morphological analyses of sections
of the AGM led the authors to identify that HSCs deﬁned by this set
of markers localize to subaortic patches and intravascular hemogenic
clusters but do not co-localize with aortic endothelial cells. Impor-
tantly, in this study the authors did not address the relationship be-
tween VE-Cadherin expression and HSCs.
Conﬂicting evidence on the intraembryonic origin of deﬁnitive hematopoietic
stem cells and the late segregation of hematopoietic and vascular lineages
The orthotopic transplantation experiments performed by F.
Dieterlen-Lièvre and numerous subsequent studies had led the
ﬁeld to the idea that deﬁnitive hematopoiesis was intraembryonic
in origin. Therefore, most of the efforts of multiple research groups
focused on understanding the dynamics of events that led to the ap-
pearance of HSCs in the embryo proper. In 2007, Samokhvalov et al.
reported that pulse labeling of yolk sac Runx1-expressing cells
with a Cre/loxP system marks a population of cells that contribute
to deﬁnitive hematopoiesis but that does not contribute to the endo-
thelial layer in the yolk sac, or to anywhere else in the embryo. These
data revived the concept that the yolk sac contributes, at least in part,
to the pool of deﬁnitive HSCs and they were interpreted as evidence
of an early segregation of hematopoietic and endothelial lineages
(Samokhvalov et al., 2007). While these data were generated using
a Runx1 hemizygous mouse that, as discussed, has a hematopoietic
phenotype, they made a strong statement about the early separation
of endothelial and hematopoietic cell lineages and appeared in con-
trast with the isolation of precursors with hemangioblast activity
from the AGM region of the E8.5–E11.5 murine embryo (Yao et al.,
2007). A potential yolk sac origin of HSCs and, to some extent, its im-
plication in the early segregation of endothelial and hematopoietic
lineages, was reinforced by two other studies that took advantage
of the Ncx1−/− mouse model. Ncx1 is a Na+/Ca2+ channel thatplays a critical role in the initiation of the heartbeat. Ncx1−/− mice
fail to initiate a heartbeat and therefore fail to initiate circulation.
Studying the Ncx1−/− model, Lux et al. (2008) showed that in the
absence of circulation there is a severe reduction in the number of
hematopoietic precursors at the level of the Para-aortic Splanchno-
pleura (PSp). Analyzing the same mutant strain, Rhodes et al.
(2008) showed that even in the absence of circulation, CD41+ hema-
topoietic cells and cells able to give a pattern of CFU compatible with
the presence of HSCs are present in the yolk sac. Importantly, these
studies used a “beatless” embryo to eliminate the redistribution of
precursors by circulating ﬂuid. However, in the absence of a heart-
beat a number of other physiologic parameters are altered, including
the hemodynamics of the vascular system.Cell fatemapping and continuous imaging of living cells prove the endothelial
origin of deﬁnitive hematopoiesis in vivo
In 2008, using a pulse labeling Cree/lox-based system, Oven et al.
were the ﬁrst to prove in vivo, that Hematopoietic Stem Cells (HSCs)
come from VE-Cadherin expressing progenitors (Zovein et al., 2008).
Oven et al. used a tamoxifen inducible VE-Cadherin Cre line crossed
with a strain carrying a lox-galactosidase gene and the induced la-
beling of VE-Cadherin+ cells with a short tamoxifen pulse at day
9.5 of development. This strategy allowed for the labeling of endo-
thelium of the aorta at the level of the AGM without labeling the
yolk sac endothelium. The progeny of the labeled VE-Cadherin+
cells was shown to ﬁrst colonize the liver and eventually the bone
marrow, the spleen and the thymus (Fig. 4). Using ex vivo organ cul-
tures in the presence of tamoxifen, the authors showed that hemo-
genic endothelium is present in both the AGM and in the yolk sac
but not in the liver. In order to rule out the possibility that HSCs
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pulse labeling experiments using a tamoxifen induciblemyocardin pro-
moter (expressed in the somatic mesoderm) and showed that myocar-
din labels the subaortic mesenchyme but not the endothelium or blood
cells. In addition to providing extremely strong evidence in support of
the existence of hemogenic endotheliumand of its critical role in the es-
tablishment of deﬁnitive hematopoiesis, this study strongly suggested
that the subaortic mesenchyme does not gain hematopoietic activity
without going through an endothelial intermediate. These ﬁndings
were to some extent conﬁrmed and expanded upon by a different
group using a similar strategy but with a loss of function approach.
Chen et al. (2009) used the Cre/lox system to selectively excise Runx1
in VE-Cadherin expressing cells and showed that a Runx1 deletion in
VE-Cadherin expressing cells abolishes intraaortic hematopoietic clus-
ters and reduces the efﬁciency of hematopoietic stem cell emergence
by 95%. These data argue that the intraaortic hematopoietic clusters
are generated from VE-Cadherin expressing cells and conﬁrm Zovein's
data by showing that the vast majority of hematopoietic stem cells
emerge fromprogenitors that express VE-Cadherin at somepoint during
ontogenesis. Moreover, these ﬁndings show that expression of Runx1 is
critical for VE-Cadherin expressing cells to acquire a hematopoietic
phenotype.
The studies just referenced clearly document that the hemogenic
endothelium exists and that it plays a critical role in hematopoiesis.
However, in both of these studies the endothelium is deﬁned merely
by the expression of VE-Cadherin. Morphological evidence clearly
supporting the endothelial origin of deﬁnitive hematopoietic precur-
sors came from the work of Boisset et al. These authors established
cultures of thick sections of post-circulation day 10.5 murine AGMs
and optimized a protocol to perform continuous confocal imaging
on these samples. Using mice expressing GFP under the control of
the promoter of hematopoietic stem cell marker Sca1 and staining
for CD31, the authors recorded real time videos of the emergence of
CD31+/Sca1+ cells from the ventrolateral aspect of the aorta (Boisset
et al., 2010).
Taken together, these reports make a compelling argument for the
endothelial origin of hematopoietic cells in the mouse. Concomitantly
with the publication of the live cell imaging of the maturation of
hemogenic endothelial cells in murine embryo culture, two different
groups produced evidence supporting the endothelial origin of hema-
topoietic stem cells in the zebraﬁsh. Using the red ﬂuorescent protein
ds-cherry under the control of the Flk1 promoter and Green Fluores-
cent Protein (GFP) under the control of the Myb promoter, Bertrand
et al. showed that hematopoietic stem cells appear in the zebraﬁsh
from a subpopulation of Flk1+ cells that upregulate Myb expression.
Importantly, due to the transparency of the zebraﬁsh embryo, the au-
thors observed, in vivo, the emergence of Flk1+/Myb+ cells from the
aortic ﬂoor as well as the presence of the ﬂuorescence markers in
adult differentiated blood cells (Bertrand et al., 2010). Kissa et al.
reported similar results when GFP was expressed under the control
of the Flk1 promoter. In this later study, the authors analyzed in detail
the maturation of hematopoietic progenitors in the vascular wall
and described the transdifferentiation of endothelial-like cells into
hematopoietic precursors through a speciﬁc set of morphological
changes deﬁned as the “endothelial hematopoietic transition”. In-
terestingly, in this study the authors found that in the absence of
Runx1, endothelial cells undergo an endothelial to hematopoietic
transition but die soon after this process (Kissa and Herbomel,
2010).
Continuous imaging of ES cell cultures sheds light on the relationship between
the hemangioblast and the hemogenic endothelium
Collectively, the data presented in the previous section show that he-
matopoietic stem cells differentiate from the hemogenic endothelium.
But, what about the hemangioblast? What is its relationship with thehemogenic endothelium? This long lasting question was tackled using
the embryonic stem cell model and live imaging of differentiating
hemangioblast colonies. Analyzing the timing of expression of hemato-
poietic and endothelial markers and the morphological changes of dif-
ferentiating ES-derived hemangioblast colonies, Lancrin et al. (2009)
conﬁrmed that hemangioblasts produce both hematopoietic cells and
endothelial cells and documented that a fraction of hemangioblast-
derived endothelial cells has a hemogenic phenotype, as shown by
their ability to produce a progeny of hematopoietic cells. The ability
of hemogenic endothelial cells to actually differentiate into hemato-
poietic progenitors is dependent on Runx1 expression. In this study,
the hemogenic endothelial phenotype was deﬁned by the surface ex-
pression of Tie2 and c-Kit in the absence of CD41 and by the ability to
produce hematopoietic colonies in response to hematopoietic cyto-
kines. Lancrin et al. reported the existence of hemogenic endothelial
cells similar those deﬁned in their ES system in murine embryos
starting at the gastrulating stage (E7.5). Results consistent with those
of Lancrin et al. were found by Eilken et al. (2009) using a similar ap-
proach. These authors isolated embryonic stem cells derived from
early endothelial precursors and followed their differentiation in pro-
hematopoietic culture conditions with continuous cell imaging. They
found that Flk1+/E-Cadherin- progenitors can generate endothelial
cell colonies and that a fraction of these endothelial cells present clear
hemogenic identity, as proven by their ability to bud off cells of the he-
matopoietic lineage.
Hemodynamic forces control hematopoiesis: a novel connection between
vascular and hematopoietic development
Since the hemogenic endothelium transiently appears in speciﬁc
sites of the vasculature, an important question is: What triggers its
maturation? In the murine embryo, intraaortic hematopoietic activity
appears around day 9.5 of development. Right before this time, the
developing vasculature experiences a critical transition, namely, the
beginning of circulation (Ji et al., 2003). With the initiation of the
heartbeat, ﬂuid starts moving inside blood vessels and the vascular
wall experiences a dramatic change in environmental conditions as
it is exposed to a set of ﬂuid mechanical forces that will shape its
identity and function (Lucitti et al., 2007; Parmar et al., 2006). These
facts provoke the question; does the presence of hemodynamic forces
trigger the maturation of vascular hematopoietic sites? The analysis
of hematopoietic activity in Ncx1−/−murine embryos that fail to ini-
tiate a heartbeat revealed defects in both intraembryonic (Lux et al.,
2008) and extraembryonic hematopoiesis (Rhodes et al., 2008). As
discussed before, an interpretation of the observed alteration in
intraembryonic hematopoiesis is that in the absence of intravascular
ﬂow hematopoietic progenitors from extraembryonic sites cannot
be transported inside the embryo proper. However, could there be
an alternate interpretation? Is there a relationship between the estab-
lishment of blood ﬂow and the maturation of hematopoietic progen-
itors in the vascular wall? Adamo et al. (2009) investigated the
relationship between ﬂuid mechanical forces and hematopoietic mat-
uration by exposing ES derived Flk1+ cells and primary murine AGM-
derived cells to ﬂuid mechanical stimulation similar to the one pre-
dicted to be present in the murine developing aorta around day
9.5–10.5 of development. When ﬂuid moves inside the vasculature,
it generates a set of biomechanical forces that can be resolved into
two principal vectors: one acting parallel to the vascular surface
(shear stress) and one acting perpendicular to the vascular wall
(blood pressure) (Davies, 1995). Adamo and colleagues focused on
shear stress, the frictional force generated by the ﬂuidic ﬂow on the
inner surface of the vascular wall. Their studies found that exposing
Flk1+ cells derived from the differentiation of embryonic stem cells
to values of shear stress similar to those predicted to be present in
the developing mouse aorta is sufﬁcient to induce Runx1 expression
and hematopoietic activity. While the mechanism of shear-stress-
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that shear-stress-mediated nitric oxide production has a permis-
sive effect on biomechanical induction of hematopoietic activity.
Furthermore, these authors further reported the ability of shear
stress to induce hematopoietic differentiation and the formation
of hemoglobinized cells from AGM-derived cells, an effect strongly
reminiscent of the in vivo observations made by Sabin almost a
century before in the chick embryo (Sabin, 1917). Importantly,
the in vivo relevance of shear stress mediated induction of hemato-
poiesis was conﬁrmed by experiments showing that shear stress
can rescue the lack of hematopoietic activity in the AGM of embry-
os that fail to initiate a heartbeat (Adamo et al., 2009; Lux et al.,
2008) (Fig. 5).
The data by Adamo et al. obtained in the murine systemwere sup-
ported by evidence produced by North et al. (2009) and Lam et al.
(2010) in the zebraﬁsh. In the context of a small molecule screening,
North et al. found that drugs that regulate blood pressure interfere
with Runx1 expression in the AGM equivalent in the zebraﬁsh.
Among these, NO donors appeared to have a strong effect on Runx1
expression independent from the establishment of blood ﬂow. Fol-
lowing up on these results, North et al. showed that zebraﬁsh embry-
os that fail to initiate a heartbeat (silent of heart mutants) fail to
express Runx1 in the AGM and that NO donors can rescue this pheno-
type. In the zebraﬁsh, Runx1 expression is considered the hallmark of
deﬁnitive hematopoiesis. In order to understand whether the rela-
tionship between NO and deﬁnitive hematopoiesis is conserved in
higher vertebrates, North et al. investigated the effect of pharmaco-
logical inhibition of NO production and of the deletion of a nitric
oxide synthase isoform (NOS3) in the developing murine embryos.
They found that both of these interventions signiﬁcantly impaired
the appearance of hematopoietic precursors in the AGM as measured
by their ability to produce short-term engraftment in irradiated mice.Fig. 5. Shear stress induces hematopoietic differentiation in primary cultures of AGM
derived cells. AGM derived cells are cultured in the presence of shear stress or under
static conditions. After 36 h, the ﬂoating cells are collected from the two experimental
conditions and pelleted in 1.5 ml tubes. While the pellet coming from cells cultured in
static conditions appears white (left), the pellet from AGM derived cells cultured in the
presence of shear stress clearly shows presence of hemoglobinized cells.Lam et al. observed real time emergence of deﬁnitive hematopoietic
progenitors by performing time-lapsemicroscopy on zebraﬁsh embryos.
These authors showed that Runx1+ cells with a migration pattern typi-
cal of deﬁnitive hematopoietic progenitors differentiate from KDR+ en-
dothelial cells. Importantly, analyzing embryos that failed to initiate a
heartbeat as a result of cardiac troponin (Tnnt2) silencing, the authors
found that emergence of Runx1+ hemogenic endothelial cells is critical-
ly dependent on blood ﬂow (Lam et al., 2010).
All of the pieces come together: our current understanding of the vascular
origin of hematopoietic precursors
The endothelium can be deﬁned from amorphological point of view
as the innermost layer of blood vessels continuously in contact with
blood (Gimbrone, 1995) or at a molecular level as a cell type character-
ized by expression of set of speciﬁc markers like VE-Cadherin (Breier et
al., 1996). According to both of these deﬁnitions, there is now over-
whelming evidence supporting the notion those hematopoietic precur-
sors come from a hemogenic cellular precursor with an endothelial
identity. In fact, precursors of hematopoietic progenitors express VE-
Cadherin (Chen et al., 2009) and they need to be resident at least for
some time in the innermost layer of the vasculature in order to be ex-
posed to shear stress (Adamo et al., 2009). Furthermore, differentia-
tion of hematopoietic precursors from the endothelial layer has been
visualized with live imaging both in cultures of murine embryo sec-
tions and in developing zebraﬁsh (Bertrand et al., 2010; Boisset et al.;
Kissa and Herbomel, 2010; Lam et al., 2010).
Importantly, the evidence obtained through continuous live imaging
of ES differentiation suggests that hemogenic endothelial cells differ-
entiate from a hemangioblast progenitor. The location of this heman-
gioblast progenitor remains to be investigated, but it is likely to be
sub-endothelial at some time-point, as suggested by multiple lines
of evidence showing both a sub-endothelial and an endothelial ori-
gin of deﬁnitive hematopoietic progenitors (Bertrand et al., 2005;
Chen et al., 2009; Zovein et al., 2008). It is possible to articulate at
least two scenarios in the context of this model. In the ﬁrst scenario,
sub-endothelial hemangioblast progenitors would differentiate from
a mesenchymal precursor and then differentiate into hemogenic en-
dothelial cells that would migrate into the endothelial layer to ac-
quire full endothelial identity and to be exposed to hemodynamic
shear stress. In the second scenario, hemangioblasts differentiated
from a mesenchymal precursor would enter the endothelial layer be-
fore differentiating further. In fact, a hemangioblast could differentiate
both into transient embryonic hematopoietic precursors that would
create some or all of the intravascular hematopoietic clusters and into
endothelial cells able to intercalate into the endothelial cell layer.
These latter cells, endowed with hemogenic capacity, would be able to
produce deﬁnitive hematopoietic precursors, in the context of the ap-
propriate microenvironment. Both these scenarios are compatible
with the live imaging data produced in the zebraﬁsh as hemangioblasts
are known to be Flk1+ (Huber et al., 2004).
Generation of deﬁnitive hematopoietic precursors from hemogenic
endothelial cells could take place in both the embryo and in the yolk
sac as proposed by apparently contradictory papers (Lux et al., 2008;
Medvinsky and Dzierzak, 1996; Samokhvalov et al., 2007). It is also in-
teresting to note that, besides being amajor site of differentiation of he-
matopoietic stem cells, the AGM appears to be a region of active
hematopoiesis as supported by the observed AGM-derived differen-
tiation of cells of the erythroid and lymphoid lineages both in vivo
(de Andres et al., 2002; Sabin, 1917) and in vitro (Adamo et al.,
2009; Yoshimoto et al., 2010).
The fate of deﬁnitive hematopoietic precursors produced from the
hemogenic endothelium requires further investigation. In vivo imaging
data in the zebraﬁsh suggests that endothelial derived hematopoietic
progenitors initially differentiate on the luminal side of the endothelium
but thenmigrate back into the sub-vascular space (Bertrand et al., 2010;
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scribed in the murine hematopoietic clusters associated with the vitel-
line arteries (Zovein et al., 2010). However, the observation of
intraluminal hematopoietic clusters associated with hemogenic endo-
thelial cells and the fact that VE-Cadherin+ hematopoietic precursors
appear in the fetal liver soon after their initial appearance in the aorta,
suggests that at least part of the hemogenic-endothelium-derived deﬁn-
itive hematopoietic precursors detach from the intraluminal hematopoi-
etic clusters and travel through the vasculature in order to reach the fetal
liver and, eventually, the other deﬁnitive hematopoietic organs (Lensch
and Daley, 2004; Zovein et al., 2008). However, the evidence summa-
rized here is mostly correlative and at present the migration pattern of
endothelial-derived hematopoietic precursors in vivo, especially in
higher vertebrates, remains unknown.
In relationship to the role of hemodynamic shear stress in hemato-
poietic development, it is now clear that this biomechanical force in-
duces Runx1 expression and embryonic hematopoiesis in the mouse
and that blood ﬂow induces markers of deﬁnitive hematopoiesis in
the zebraﬁsh. These data suggest a role for hemodynamic shear stress
in promoting the maturation of the hemogenic endothelium toward a
deﬁnitive hematopoietic phenotype. This interpretation is in line with
the absence of in vitro deﬁnitive hematopoietic colony forming activity
in the PSp of Ncx1−/−murine embryos (Lux et al., 2008), with the ob-
servation that the appearance of Sca1+/CD31+ cells is not detectable
in day 9.5 murine aorta but it is measurable in day 10.5 post circulation
aorta (Boisset et al., 2010), and with the observation that Runx1 upre-
gulation in the endothelium is critical for the endothelial to hematopoi-
etic transition but not thereafter (Chen et al., 2009). Importantly, the
functional differences between precursors that emerge in the absence
and presence of continuous biomechanical stimulation remain un-
known. Analysis of the effect of hemodynamic shear stress on long
term repopulating hematopoietic stem cells is needed in order to shed
light on this important physiological process and to assess the role of he-
modynamic shear stress in the maturation of deﬁnitive hematopoietic
progenitors (Fig. 6).Fig. 6. Model of the maturation of hematopoietic progenitors from the hemogenic endothelium
thelial layer of the ventrolateral aspect of the aorta at the level of the PSp/AGM is endowe
hematopoietic transition and mature into hematopoietic precursors protruding into the v
metric divisions. It is not clear weather only some of the hemogenic endothelial cells can
hematopoietic colonies produced from the hemogenic endothelium are heterogeneous in
as hematopoietic stem cells (HSC). The presence of shear stress inside the developing aor
lium is the product of differentiation or maturation of hemangioblasts. The precise locatio
could be present only in the perivascular space (outside the vascular smooth muscle cell la
lial layer. Alternatively, the hemangioblasts could be present in the sub-endothelial spaceConclusions
In 1899Vander Stricht described for theﬁrst time the presence of he-
matopoietic activity in the wall of the developing aorta of a vertebrate
(Van-der-Stricht, 1899). More than a century later, in light of decades
of investigation, we can now state that what Van der Stricht reported
was probably the ﬁrst observation of hematopoietic development from
the vasculature. In fact, we now know that hematopoietic and vascular
lineages donot segregate until late in embryogenesis and that the second
wave of hematopoiesis comes from cells that have already acquired an
endothelial phenotype, in the embryo proper as well as in extra-
embryonic tissues.
The development of deﬁnitive hematopoietic precursors is a com-
plex event controlled by a number of different developmental signals
(Dzierzak and Speck, 2008). Interestingly, in support of the tight rela-
tionship between vascular and hematopoietic development, recent
data has shown that intravascular hemodynamic shear stress pro-
motes the maturation, differentiation or expansion of deﬁnitive he-
matopoietic stem cells. This effect could be described as a
“mechano-activated switch” from embryonic to deﬁnitive hematopoie-
sis or as a mechano-driven maturation of hematopoietic progenitors in
the endothelial layer toward fully functional hematopoietic stem cells.
The fundamental question of the vascular origin of hematopoiesis
seems to be answered. However, as it happens in science, multiple
other questions have been generated. In fact, while we know that he-
matopoietic cells come from endothelial precursors, we do not know
the origin of these precursors and whether they are only transiently
endothelial or they constitute a stable subset of the embryonic endo-
thelium in speciﬁc phases of development. Moreover, we do not
know what the hemogenic endothelium differentiates into. Does the
hemogenic endothelium differentiate into hematopoietic stem cells,
into hematopoietic progenitors that need to mature and expand
into hematopoietic organs, or does it differentiate into both multipo-
tent and pluripotent progenitors, as suggested by recent evidence
pointing at the hemogenic endothelium as the source of B cellin the developing aorta at the level of the AGM. In the mid-gestation embryo, the endo-
d with hemogenic capacity. Hemogenic endothelial cells can undergo an endothelial/
essel lumen. This could happen either through transdifferentiation or through asym-
actually give rise to hematopoietic colonies or all do it in an asynchronous way. The
their composition and may contain cells of multiple hematopoietic lineages as well
ta promotes the maturation of the hemogenic endothelium. The hemogenic endothe-
n of the hemangioblasts during development remains to be clariﬁed. Hemangioblasts
yer) and there produce hemogenic endothelial cells able to migrate into the endothe-
or even within the endothelial layer.
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ship between the hemogenic endothelium and the hemangioblast has
been investigated in vitro, the in vivo dynamics of hemangioblast dif-
ferentiation are yet to be explored. Furthermore, many aspects of the
biomechanical control of hematopoiesis require further investigation.
For example: What are the molecular characteristics of the cells acti-
vated by shear stress to induce hematopoiesis? Is this a differentia-
tion effect or an expansion effect? What is the role of shear stress in
the differentiation of long-term hematopoietic stem cells? And, ﬁnal-
ly, what are the molecular mechanism of the hemodynamic shear
stress-mediated Runx1 upregulation and promotion of hematopoie-
sis? Furthermore, cells reminiscent of the hemangioblast and of the
hemogenic endothelium have been described in adult, human bone
marrow and in human cord blood, respectively (Pelosi et al., 2002;
Wu et al., 2007), as well is in organs not typically classiﬁed as hema-
topoietic (Sun et al., 2010). Do hemogenic endothelium and hemody-
namic shear stress have a role in hematopoiesis in the adult? The
development of non-differentiating culture conditions to grow and
expand hemangioblasts and hemogenic endothelial cells will be nec-
essary to better answer many of these questions and to continue gen-
erating knowledge critical not only for our understanding of the
relationship between vascular and hematopoietic development but
also for the in vitro differentiation of hematopoietic precursors pur-
sued in the context of regenerative medicine applications.References
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